少妇人妻无码专区毛片_蝌蚪视频窝在线播放_欧美性色欧美A在线播放_尤物在线精品视频_欧美精品国产一区二区三区_在线观看成人无码中文AV天堂不卡

三石風險投資 Third Rock Ventures  
Third Rock Ventures是一家成立于2007年的醫療健康領域風險投資公司，總部在波士頓和三藩，募集基金高達13億美金。到現在為止，Third Rock投資給31家生物醫療公司。其中5家從事的是癌癥治療相關的業務。

Third Rock Ventures was founded in 2007 with the mission to launch transforming companies. We set out to build a different firm – a firm that was squarely focused on launching exceptional healthcare companies with passionate entrepreneurs, working in areas of disruptive science and medicine to make a difference in the lives of patients.

We are not just launching new healthcare companies - we are rapidly growing them, advancing pipelines to the clinic and developing new products. In just six short years, and during a period of time when early stage investing has been in flux, we have successfully raised more than $1.3 billion and invested in more than 31 companies to accomplish this mission. We truly believe that nothing is impossible.

We take investments in our companies and our people seriously, as we strive to be the best business partners in the world. By working closely with the scientific and business communities, we seek to identify the most promising opportunities for the future of medicine and then build the team and company structure to make this visionary science a business reality. Our portfolio companies are formed around disruptive areas of science and medicine and the convergence of technology and genomics, and many have been developed as part of collaborations with big pharma and big biotech. Collaborative company building is the future, and Third Rock and its portfolio companies are at the forefront of this paradigm shift with early-stage yet highly valued strategic partnerships.

Our approach is bold, our thinking is outside-of-the-box and we apply the same innovative spirit to our deal-making as we do to our companies' science. Together, this approach is designed to achieve our ultimate goal – launching and building transforming companies that make a difference for patients through breakthroughs in medicine.